Annex III NOTIFICATION OF SERIOUS ADVERSE REACTIONSF1 United Kingdom Original text. Later amendments are not shown. PART ARapid notification for suspected serious adverse reactions PART BConclusions of Serious Adverse Reactions Investigation Annotations Textual amendments F1 Substituted by Commission Directive (EU) 2015/565 of 8 April 2015 amending Directive 2006/86/EC as regards certain technical requirements for the coding of human tissues and cells (Text with EEA relevance). ← Division F Annex III Division PART A →